首页 > 最新文献

World Psychiatry最新文献

英文 中文
Evolutionary psychiatry: foundations, progress and challenges. 进化精神病学:基础、进展与挑战。
IF 73.3 1区 医学 Q1 Medicine Pub Date : 2023-06-01 DOI: 10.1002/wps.21072
Randolph M Nesse

Evolutionary biology provides a crucial foundation for medicine and behavioral science that has been missing from psychiatry. Its absence helps to explain slow progress; its advent promises major advances. Instead of offering a new kind of treatment, evolutionary psychiatry provides a scientific foundation useful for all kinds of treatment. It expands the search for causes from mechanistic explanations for disease in some individuals to evolutionary explanations for traits that make all members of a species vulnerable to disease. For instance, capacities for symptoms such as pain, cough, anxiety and low mood are universal because they are useful in certain situations. Failing to recognize the utility of anxiety and low mood is at the root of many problems in psychiatry. Determining if an emotion is normal and if it is useful requires understanding an individual's life situation. Conducting a review of social systems, parallel to the review of systems in the rest of medicine, can help achieve that understanding. Coping with substance abuse is advanced by acknowledging how substances available in modern environments hijack chemically mediated learning mechanisms. Understanding why eating spirals out of control in modern environments is aided by recognizing the motivations for caloric restriction and how it arouses famine protection mechanisms that induce binge eating. Finally, explaining the persistence of alleles that cause serious mental disorders requires evolutionary explanations of why some systems are intrinsically vulnerable to failure. The thrill of finding functions for apparent diseases is evolutionary psychiatry's greatest strength and weakness. Recognizing bad feelings as evolved adaptations corrects psychiatry's pervasive mistake of viewing all symptoms as if they were disease manifestations. However, viewing diseases such as panic disorder, melancholia and schizophrenia as if they are adaptations is an equally serious mistake in evolutionary psychiatry. Progress will come from framing and testing specific hypotheses about why natural selection left us vulnerable to mental disorders. The efforts of many people over many years will be needed before we will know if evolutionary biology can provide a new paradigm for understanding and treating mental disorders.

进化生物学为医学和行为科学提供了一个重要的基础,而这正是精神病学所欠缺的。它的缺失有助于解释进展缓慢的原因,而它的出现则有望带来重大进展。与其说进化精神病学提供了一种新的治疗方法,不如说它提供了一个对所有治疗方法都有用的科学基础。它将寻找病因的范围从对某些个体疾病的机理解释扩大到对使一个物种的所有成员都易患病的特征的进化解释。例如,疼痛、咳嗽、焦虑和情绪低落等症状的能力是普遍存在的,因为它们在某些情况下是有用的。没有认识到焦虑和情绪低落的作用是精神病学中许多问题的根源。判断一种情绪是否正常,是否有用,需要了解个人的生活状况。对社会系统进行审查,就像对其他医学系统进行审查一样,有助于实现这种理解。认识到现代环境中的物质如何劫持以化学为媒介的学习机制,有助于应对药物滥用问题。认识到限制热量的动机以及限制热量如何引起饥荒保护机制,从而诱发暴饮暴食,有助于理解在现代环境中饮食失控的原因。最后,要解释导致严重精神障碍的等位基因的持续存在,就需要从进化角度解释为什么某些系统在本质上容易失败。为明显的疾病寻找功能的快感是进化精神病学最大的优势和弱点。认识到不良情绪是进化的适应,可以纠正精神病学普遍存在的错误,即把所有症状都看成是疾病的表现。然而,将恐慌症、忧郁症和精神分裂症等疾病视为适应症,同样是进化精神病学的一个严重错误。关于为什么自然选择会让我们容易患上精神疾病的具体假说的提出和验证,将会带来进步。在我们知道进化生物学能否为理解和治疗精神障碍提供新的范式之前,还需要许多人多年的努力。
{"title":"Evolutionary psychiatry: foundations, progress and challenges.","authors":"Randolph M Nesse","doi":"10.1002/wps.21072","DOIUrl":"10.1002/wps.21072","url":null,"abstract":"<p><p>Evolutionary biology provides a crucial foundation for medicine and behavioral science that has been missing from psychiatry. Its absence helps to explain slow progress; its advent promises major advances. Instead of offering a new kind of treatment, evolutionary psychiatry provides a scientific foundation useful for all kinds of treatment. It expands the search for causes from mechanistic explanations for disease in some individuals to evolutionary explanations for traits that make all members of a species vulnerable to disease. For instance, capacities for symptoms such as pain, cough, anxiety and low mood are universal because they are useful in certain situations. Failing to recognize the utility of anxiety and low mood is at the root of many problems in psychiatry. Determining if an emotion is normal and if it is useful requires understanding an individual's life situation. Conducting a review of social systems, parallel to the review of systems in the rest of medicine, can help achieve that understanding. Coping with substance abuse is advanced by acknowledging how substances available in modern environments hijack chemically mediated learning mechanisms. Understanding why eating spirals out of control in modern environments is aided by recognizing the motivations for caloric restriction and how it arouses famine protection mechanisms that induce binge eating. Finally, explaining the persistence of alleles that cause serious mental disorders requires evolutionary explanations of why some systems are intrinsically vulnerable to failure. The thrill of finding functions for apparent diseases is evolutionary psychiatry's greatest strength and weakness. Recognizing bad feelings as evolved adaptations corrects psychiatry's pervasive mistake of viewing all symptoms as if they were disease manifestations. However, viewing diseases such as panic disorder, melancholia and schizophrenia as if they are adaptations is an equally serious mistake in evolutionary psychiatry. Progress will come from framing and testing specific hypotheses about why natural selection left us vulnerable to mental disorders. The efforts of many people over many years will be needed before we will know if evolutionary biology can provide a new paradigm for understanding and treating mental disorders.</p>","PeriodicalId":23858,"journal":{"name":"World Psychiatry","volume":"22 2","pages":"177-202"},"PeriodicalIF":73.3,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10168175/pdf/WPS-22-177.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9436375","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Biomarkers in psychiatric disorders: status quo, impediments and facilitators. 精神疾病的生物标志物:现状、障碍和促进因素。
IF 73.3 1区 医学 Q1 Medicine Pub Date : 2023-06-01 DOI: 10.1002/wps.21071
Michael Berk
World Psychiatry 22:2 June 2023 forces have pushed us to a genetic sweet spot regarding a cer­ tain trait that does not tail off gradually but, with relatively minor changes in the allele distribution, suddenly transforms into dis­ order. Many psychological traits may need to stay within narrow bounds to enable adaptive social interaction, so small variations may yield cliff­ edge disorder vulnerability. Emergent properties of specific allele combinations may exist for other unexpected reasons. For example, a recent study found that certain combinations of positively selected alleles yield­ ing cognitive advantage increased risk for autism spectrum dis­ order. Moreover, beyond alleles, at the trait level, there can be dysfunction­ causing combinations of individually selected posi­ tive traits (e.g., certain combinations of individually selected per­ sonality traits can yield personality disorders such as psychopa­ thy). All of this goes to show that it is not dimensionality per se but the way selective processes operated on various elements on a dimension that determines normality and disorder. Evolutionary psychiatry’s role thus transcends the current dis­ pute over psychiatry’s nosological future. Whichever proposal triumphs, psychiatry’s status as a medical discipline requires distinguishing normal variation from mental disorder, which rests on understanding human psychobiological design. Symp­ tom networks, extremes on symptom dimensions, and intense brain circuitry activations can be normal or abnormal depend­ ing on context. These proposals, whatever their merits, rearrange the symptomatic deck chairs on our nosological Titanic without addressing the root problem: i.e., that DSM psychiatric nosology is sinking due to lack of attention to the evolved nature of human normality, yielding invalid normal/disorder demarcations. Only evolutionary psychiatry provides a scientifically defensible answer to the fundamental nosological normal/disorder “demar­ cation” problem. Because the way people are biologically designed does not always fit social values and ideals, evolutionary psychiatry treads on potentially controversial ground. There is a tension between social idealizations – what we want to believe about ourselves and demand of our society’s members – versus the scientific reality of human nature. M. Foucault correctly observed that a society’s view of human nature tends to be distorted and permeated by its values and biases, rationalizing its efforts at social control. If psychiatry is to make scientific progress, it must understand the truth of human nature that lies beyond cultural preconceptions as a basis for valid diagnostic concepts that support psychiatric science. The promise of evolutionary psychiatry is that it is the one subdiscipline of psychiatry devoted to realizing this foundational goal.
{"title":"Biomarkers in psychiatric disorders: status quo, impediments and facilitators.","authors":"Michael Berk","doi":"10.1002/wps.21071","DOIUrl":"https://doi.org/10.1002/wps.21071","url":null,"abstract":"World Psychiatry 22:2 June 2023 forces have pushed us to a genetic sweet spot regarding a cer­ tain trait that does not tail off gradually but, with relatively minor changes in the allele distribution, suddenly transforms into dis­ order. Many psychological traits may need to stay within narrow bounds to enable adaptive social interaction, so small variations may yield cliff­ edge disorder vulnerability. Emergent properties of specific allele combinations may exist for other unexpected reasons. For example, a recent study found that certain combinations of positively selected alleles yield­ ing cognitive advantage increased risk for autism spectrum dis­ order. Moreover, beyond alleles, at the trait level, there can be dysfunction­ causing combinations of individually selected posi­ tive traits (e.g., certain combinations of individually selected per­ sonality traits can yield personality disorders such as psychopa­ thy). All of this goes to show that it is not dimensionality per se but the way selective processes operated on various elements on a dimension that determines normality and disorder. Evolutionary psychiatry’s role thus transcends the current dis­ pute over psychiatry’s nosological future. Whichever proposal triumphs, psychiatry’s status as a medical discipline requires distinguishing normal variation from mental disorder, which rests on understanding human psychobiological design. Symp­ tom networks, extremes on symptom dimensions, and intense brain circuitry activations can be normal or abnormal depend­ ing on context. These proposals, whatever their merits, rearrange the symptomatic deck chairs on our nosological Titanic without addressing the root problem: i.e., that DSM psychiatric nosology is sinking due to lack of attention to the evolved nature of human normality, yielding invalid normal/disorder demarcations. Only evolutionary psychiatry provides a scientifically defensible answer to the fundamental nosological normal/disorder “demar­ cation” problem. Because the way people are biologically designed does not always fit social values and ideals, evolutionary psychiatry treads on potentially controversial ground. There is a tension between social idealizations – what we want to believe about ourselves and demand of our society’s members – versus the scientific reality of human nature. M. Foucault correctly observed that a society’s view of human nature tends to be distorted and permeated by its values and biases, rationalizing its efforts at social control. If psychiatry is to make scientific progress, it must understand the truth of human nature that lies beyond cultural preconceptions as a basis for valid diagnostic concepts that support psychiatric science. The promise of evolutionary psychiatry is that it is the one subdiscipline of psychiatry devoted to realizing this foundational goal.","PeriodicalId":23858,"journal":{"name":"World Psychiatry","volume":"22 2","pages":"174-176"},"PeriodicalIF":73.3,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10168162/pdf/WPS-22-174.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9436369","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
The promise of evolutionary psychiatry. 进化精神病学的前景。
IF 73.3 1区 医学 Q1 Medicine Pub Date : 2023-06-01 DOI: 10.1002/wps.21070
Jerome C Wakefield
{"title":"The promise of evolutionary psychiatry.","authors":"Jerome C Wakefield","doi":"10.1002/wps.21070","DOIUrl":"https://doi.org/10.1002/wps.21070","url":null,"abstract":"","PeriodicalId":23858,"journal":{"name":"World Psychiatry","volume":"22 2","pages":"173-174"},"PeriodicalIF":73.3,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10168155/pdf/WPS-22-173.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9442878","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
WPA education initiatives in the triennium 2020-2023. 2020-2023三年期的《世界行动纲领》教育倡议。
IF 73.3 1区 医学 Q1 Medicine Pub Date : 2023-06-01 DOI: 10.1002/wps.21107
Roger M K Ng
{"title":"WPA education initiatives in the triennium 2020-2023.","authors":"Roger M K Ng","doi":"10.1002/wps.21107","DOIUrl":"https://doi.org/10.1002/wps.21107","url":null,"abstract":"","PeriodicalId":23858,"journal":{"name":"World Psychiatry","volume":"22 2","pages":"346-347"},"PeriodicalIF":73.3,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10168174/pdf/WPS-22-346.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9442884","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cannabis, cannabinoids and psychosis: a balanced view. 大麻、大麻素和精神病:一种平衡的观点。
IF 73.3 1区 医学 Q1 Medicine Pub Date : 2023-06-01 DOI: 10.1002/wps.21075
Deepak Cyril D'Souza
{"title":"Cannabis, cannabinoids and psychosis: a balanced view.","authors":"Deepak Cyril D'Souza","doi":"10.1002/wps.21075","DOIUrl":"10.1002/wps.21075","url":null,"abstract":"","PeriodicalId":23858,"journal":{"name":"World Psychiatry","volume":"22 2","pages":"231-232"},"PeriodicalIF":73.3,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10168157/pdf/WPS-22-231.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9436376","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Wellcome Trust: new funding for mental health science. 威康信托基金:为心理健康科学提供新资金。
IF 73.3 1区 医学 Q1 Medicine Pub Date : 2023-06-01 DOI: 10.1002/wps.21077
Miranda Wolpert, Lynsey Bilsland, Niall Boyce, Kate Martin, Catherine Sebastian
{"title":"The Wellcome Trust: new funding for mental health science.","authors":"Miranda Wolpert, Lynsey Bilsland, Niall Boyce, Kate Martin, Catherine Sebastian","doi":"10.1002/wps.21077","DOIUrl":"10.1002/wps.21077","url":null,"abstract":"","PeriodicalId":23858,"journal":{"name":"World Psychiatry","volume":"22 2","pages":"234-235"},"PeriodicalIF":73.3,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10168141/pdf/WPS-22-234.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9436380","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The future of psychopharmacology: challenges beyond efficacy and tolerability. 精神药理学的未来:超越疗效和耐受性的挑战。
IF 73.3 1区 医学 Q1 Medicine Pub Date : 2023-02-01 DOI: 10.1002/wps.21065
Robin Emsley
World Psychiatry 22:1 February 2023 3. Koblan KS, Kent J, Hopkins SC et al. N Engl J Med 2020;382:1497-506. 4. Thase ME. CNS Spectr 2017;22:39-48. 5. Tabuteau H, Jones A, Anderson A et al. Am J Psychiatry 2022; doi: 10.1176/appi.ajp.21080800. 6. Fava M, Stahl S, Pani L et al. Am J Psychiatry 2021; 179:122-31. 7. Gunduz-Bruce H, Silber C, Kaul I et al. N Engl J Med 2019;381:903-11. 8. Davis AK, Barrett FS, May DG et al. JAMA Psychiatry 2021;78:481-9.
{"title":"The future of psychopharmacology: challenges beyond efficacy and tolerability.","authors":"Robin Emsley","doi":"10.1002/wps.21065","DOIUrl":"https://doi.org/10.1002/wps.21065","url":null,"abstract":"World Psychiatry 22:1 February 2023 3. Koblan KS, Kent J, Hopkins SC et al. N Engl J Med 2020;382:1497-506. 4. Thase ME. CNS Spectr 2017;22:39-48. 5. Tabuteau H, Jones A, Anderson A et al. Am J Psychiatry 2022; doi: 10.1176/appi.ajp.21080800. 6. Fava M, Stahl S, Pani L et al. Am J Psychiatry 2021; 179:122-31. 7. Gunduz-Bruce H, Silber C, Kaul I et al. N Engl J Med 2019;381:903-11. 8. Davis AK, Barrett FS, May DG et al. JAMA Psychiatry 2021;78:481-9.","PeriodicalId":23858,"journal":{"name":"World Psychiatry","volume":"22 1","pages":"82-83"},"PeriodicalIF":73.3,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9840489/pdf/WPS-22-82.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9164324","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ): developing tools to enable early intervention in the psychosis high risk state. 加速药物伙伴关系®精神分裂症(AMP® SCZ):开发工具,以实现对精神病高风险状态的早期干预。
IF 73.3 1区 医学 Q1 Medicine Pub Date : 2023-02-01 DOI: 10.1002/wps.21038
Linda S Brady, Carlos A Larrauri
{"title":"Accelerating Medicines Partnership<sup>®</sup> Schizophrenia (AMP<sup>®</sup> SCZ): developing tools to enable early intervention in the psychosis high risk state.","authors":"Linda S Brady, Carlos A Larrauri","doi":"10.1002/wps.21038","DOIUrl":"10.1002/wps.21038","url":null,"abstract":"","PeriodicalId":23858,"journal":{"name":"World Psychiatry","volume":"22 1","pages":"42-43"},"PeriodicalIF":73.3,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9840500/pdf/WPS-22-42.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9164326","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
WPA Working Group on Defining and Managing Autism Spectrum Disorder: spreading knowledge for the next generations of psychiatrists. 定义和管理自闭症谱系障碍工作组:为下一代精神病学家传播知识。
IF 73.3 1区 医学 Q1 Medicine Pub Date : 2023-02-01 DOI: 10.1002/wps.21051
Marco O Bertelli, Annamaria Bianco, Luis Salvador-Carulla, Afzal Javed
{"title":"WPA Working Group on Defining and Managing Autism Spectrum Disorder: spreading knowledge for the next generations of psychiatrists.","authors":"Marco O Bertelli,&nbsp;Annamaria Bianco,&nbsp;Luis Salvador-Carulla,&nbsp;Afzal Javed","doi":"10.1002/wps.21051","DOIUrl":"https://doi.org/10.1002/wps.21051","url":null,"abstract":"","PeriodicalId":23858,"journal":{"name":"World Psychiatry","volume":"22 1","pages":"168-169"},"PeriodicalIF":73.3,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9840480/pdf/WPS-22-168.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9164331","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association between stressful life events and psychosis relapse: a 2-year prospective study in first-episode psychosis. 应激性生活事件与精神病复发之间的关系:一项针对首发精神病的2年前瞻性研究。
IF 73.3 1区 医学 Q1 Medicine Pub Date : 2023-02-01 DOI: 10.1002/wps.21046
Marco Colizzi, Alexis E Cullen, Natasha Martland, Marta Di Forti, Robin Murray, Tabea Schoeler, Sagnik Bhattacharyya
{"title":"Association between stressful life events and psychosis relapse: a 2-year prospective study in first-episode psychosis.","authors":"Marco Colizzi,&nbsp;Alexis E Cullen,&nbsp;Natasha Martland,&nbsp;Marta Di Forti,&nbsp;Robin Murray,&nbsp;Tabea Schoeler,&nbsp;Sagnik Bhattacharyya","doi":"10.1002/wps.21046","DOIUrl":"https://doi.org/10.1002/wps.21046","url":null,"abstract":"","PeriodicalId":23858,"journal":{"name":"World Psychiatry","volume":"22 1","pages":"159-160"},"PeriodicalIF":73.3,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9840498/pdf/WPS-22-159.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9164757","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
期刊
World Psychiatry
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1